Analysis: Colgate CEO faces acquisition decision

Colgate-Palmolive Co. CEO Reuben Mark, known for careful acquisition moves, isn't likely to bid on Pfizer's $12 billion consumer-health business, for which final bids are due in the next several days, according to this writer. Though he may try to purchase the company's Listerine line in a $4 to $5 billion deal.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Executive Chef
Whole Foods
Bellevue, WA
Sous Chef
Salt Lake City, UT
Executive Chef
The Lodge & Spa at Callaway Gardens Job
Pine Mountain, GA